Ponencia

Chronic migraine: treatment

J. Pascual [REV NEUROL 2012;54 (Supl. 2):S31-S38] PMID: 22532241 DOI: https://doi.org/10.33588/rn.54S02.2011572

OPEN ACCESS

Volumen 54 | Number S02 | Nº of views of the article 24.940 | Nº of PDF downloads 3.231 | Article publication date 10/04/2012

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

We define chronic migraine as that clinical situation in which migraine attacks appear 15 or more days per month. Until recently, and in spite of its negative impact, patients with chronic migraine were excluded of the clinical trials. This manuscript revises the current treatment of chronic migraine. The first step should include the avoidance of potential precipitating/aggravating factors for chronic migraine, mainly analgesic overuse and the treatment of comorbid disorders, such as anxiety and depression. The symptomatic treatment should be based on the use of nonsteroidal anti-inflammatory agents and triptans (in this case < 10 days per month). It is necessary to avoid the use of combined analgesics, opoids and ergotamine-containing medications. Preventive treatment includes a ‘transitional’ treatment with nonsteroidal anti-inflammatory agents or steroids, while preventive treatment exerts its actions. Even though those medications efficacious in episodic migraine prevention are used, the only drugs with demonstrated efficacy in the preventive treatment of chronic migraine are topiramate and pericranial infiltrations of Onabotulinumtoxin A. KeywordsBotulinum toxin type A Chronic migraine Onabotulinumtoxin A Topiramate CategoriesCefalea y Migraña Dolor

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Ponencia

Chronic migraine: treatment

¡CONVIÉRTASE EN USUARIO PREMIUM DE NEUROLOGIA.COM!

Al hacerse premium, está apoyándonos para que Revista de Neurología siga siendo uno de los referentes de habla hispana en la difusión del conocimiento en neurociencias. ¡Gratuita tanto para autores como para todos los usuarios de la web!